The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Baxter International Inc

NYSE: BAX
Last

(U.S.) $38.75

Today's change+0.16 +0.41%
Updated August 28 4:00 PM EDT. Delayed by at least 15 minutes.
 

Baxter International Inc

NYSE: BAX
Last

(U.S.) $38.75

Today's change+0.16 +0.41%
Updated August 28 4:00 PM EDT. Delayed by at least 15 minutes.

Baxter International Inc up (U.S.)$0.16

Baxter International Inc closed up Friday by (U.S.)$0.16 or 0.41% to (U.S.)$38.75. Over the last five days, shares have gained 1.23%, but are down 47.13% for the last year to date. Shares have underperformed the S&P 500 by 47.88% during the last year.

Key company metrics

  • Open(U.S.) $38.50
  • Previous close(U.S.) $38.59
  • High(U.S.) $39.05
  • Low(U.S.) $38.34
  • Bid / Ask-- / --
  • YTD % change-47.13%
  • Volume6,382,399
  • Average volume (10-day)9,064,025
  • Average volume (1-month)13,764,791
  • Average volume (3-month)11,011,446
  • 52-week range(U.S.) $34.50 to (U.S.) $75.36
  • Beta0.61
  • Trailing P/E12.29×
  • P/E 1 year forward29.47×
  • Forward PEG7.02×
  • Indicated annual dividend(U.S.) $0.46
  • Dividend yield1.19%
  • Trailing EPS(U.S.) $3.15
Updated August 28 4:00 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+10.58%

Based on its net profit margin of 10.58%, Baxter International Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.71%Sector:HealthcareIndustry:Medical Equipment, Supplies & Distribution
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q1/2015Q4/2014Q3/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014
Revenue3,8933,7644,4724,197
Total other revenue--------
Total revenue3,8933,7644,4724,197
Gross profit1,9261,7952,2022,074
Total cost of revenue1,9671,9692,2702,123
Total operating expense3,4583,2783,7253,619
Selling / general / administrative951887970921
Research & development292298305292
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)248124180283
Other operating expenses, total--------
Operating income435486747578
Interest income (expense), net non-operating-40-35-36-36
Gain (loss) on sale of assets--------
Other--------
Income before tax468530598586
Income after tax336420524447
Income tax, total13211074139
Net income332430953468
Total adjustments to net income--------
Net income before extra. items336420524447
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items336420524447
Inc. avail. to common incl. extra. items332430953468
Diluted net income332430953468
Dilution adjustment--------
Diluted weighted average shares549548547547
Diluted EPS excluding extraordinary itemsvalue per share0.610.770.960.82
Dividends per sharevalue per share0.520.520.520.52
Diluted normalized EPSvalue per share1.000.911.251.21